+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AB Science - logo

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

Alzheimer's Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Global Melanoma Drug Market by Type (Acral Lentiginous Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma), Product (Adjuvant Therapy, Biochemotherapy, Chemotherapy Drugs), Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Melanoma Drug Market by Type (Acral Lentiginous Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma), Product (Adjuvant Therapy, Biochemotherapy, Chemotherapy Drugs), Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 200 Pages
  • Japan
From
Alzheimer's Disease - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Alzheimer's Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 255 Pages
  • Global
From
Alzheimer Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Alzheimer Drugs Market - Forecast (2022 - 2027)

  • Report
  • February 2022
  • 111 Pages
  • Global
From
Metastatic colorectal cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic colorectal cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 250 Pages
  • Global
From
Asthma - Pipeline Insight, 2024 - Product Thumbnail Image

Asthma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Pancreatic Cancer - Competitive landscape, 2023 - Product Thumbnail Image

Pancreatic Cancer - Competitive landscape, 2023

  • Report
  • April 2023
  • 450 Pages
  • Global
From
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Melanoma Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Metastatic Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Systemic Mastocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 53 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • April 2023
  • 397 Pages
  • Global
From
Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Thumbnail Image

Multiple Sclerosis (MS) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • April 2023
  • 117 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 898 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 672 Pages
  • Global
From
Amyotrophic Lateral Sclerosis - Global Strategic Business Report - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Global Strategic Business Report

  • Report
  • April 2024
  • 183 Pages
  • Global
From
Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 155 Pages
  • Global
From
Loading Indicator